JS BIOFUTURE INVEST ApS: Financial statements 2018
CVR: 31080983
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
JS BIOFUTURE INVEST ApS (CVR 31080983) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -4,375 and a net result of DKK -13,469 compared with DKK 2,745 the year before. Equity in the 2018 report amounted to DKK 12,994. The solvency ratio was 6.8%.
- Gross Profit
- DKK -4,375
- Profit/Loss
- DKK -13,469
- Equity
- DKK 12,994
- Total Assets
- DKK 189,937
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -4 t. | -13 t. | 13 t. | - |
| 2017 | - | -8 t. | 3 t. | 26 t. | - |
| 2016 | - | -4 t. | -20 t. | 24 t. | - |
| 2015 | - | -9 t. | 5 t. | 43 t. | - |
| 2014 | - | -8 t. | -555 | 38 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
JS BIOFUTURE INVEST ApS has published its annual report for 2017. Gross profit came to DKK -7,500, and the net result was DKK 2,745.
About JS BIOFUTURE INVEST ApS
JS BIOFUTURE INVEST ApS is a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2007. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named ApS KBUS 17 NR. 6222. The management consists of Jørgen Schøller. The company is owned by Jørgen Schøller and Anna Carina Wiborg Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,598 and a net result of DKK 1,492,381 compared with DKK -8,609 the year before. Equity in the 2025 report amounted to DKK 1,706,887.